European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra
Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text
AbbVie Symposium at ECCO 2020: The Illusion of Remission - EMG-Health
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease | NEJM Evidence
Induction and Maintenance of Remission in IBD: Where Are We Coming from; Where Could We Go?
Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives - Rune Wilkens, Kerri L. Novak, Christian Maaser, Remo Panaccione, Torsten Kucharzik, 2021
PDF) European Crohn's and Colitis Organization (ECCO)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical M
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
Efficacy & Remission Data | SKYRIZI® (risankizumab-rzaa)
Frontiers | Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
ECCO
ECCO-EFCCA Patient Guidelines on Ulcerative Colitis (UC) Introduction
PDF] Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. | Semantic Scholar